Reference | Study design | Exercise | Comparator | Sample size | Age (years)* | ppFEV1* | Clinical stability | Relevant outcomes | |||
Ex | Com | Ex | Com | Ex | Com | ||||||
Exercise versus rest | |||||||||||
Baldwin et al 16 | Crossover | Mixed | Rest | 8 | 18–27 | 63.6 (6.6)† | Acute exacerbation | Respiratory function tests, sputum weight | |||
Dwyer et al 17 | Crossover | Cycle ergometry treadmill | Rest | 14 | 18–44, 27 (7)‡ | 19–108, 55 (27)‡ | Stable | Respiratory function tests, participant ease of expectoration | |||
Kreimler et al
(Radkte et al)19 | Crossover | Cycle ergometry trampoline | Rest (billiards) | 12 | 15.9–28.9, 20.8 (3.5)‡ | 33.3–89.9, 62.8 (17.7)‡ | Not specified | Respiratory function tests, sputum weight | |||
Exercise versus rest/traditional ACT | |||||||||||
Dwyer et al 18 | Crossover | Treadmill | Rest Flutter | 24 | 19–48, 30 (8)‡ | 28–86, 51 (18)‡ | Stable | Respiratory function tests, participant ease of expectoration, adverse events | |||
Dwyer et al 20 | Crossover | Treadmill | Rest PEP | 15 | 18–48, 27 (9)‡ | 31–113, 65 (23)‡ | Stable | Mucociliary clearance, adverse events | |||
Exercise versus traditional ACT | |||||||||||
Aquino et al 21 | Crossover | Active video game | PEP | 13 | 7–29 | 46–102 | Stable | Sputum weight | |||
Balestri et al 22 | Crossover | Cycle ergometry | Bubble PEP | 13 | 10–41 | 54–95 | Stable | Sputum weight | |||
Bilton et al (Bilton et al)23 | Crossover | Cycle ergometry | ACBT with PD | 18 | 16–34 | 18–98 | Stable | Respiratory function tests, sputum weight, participant perception and treatment preference, adverse events | |||
Cerny24 | RCT | Cycle ergometry | PD with P&V | 9 | 8 | 15.4 (4.9)‡ | 15.9 (4.9)‡ | NS | NS | Acute exacerbation | Respiratory function tests, sputum weight |
Falk et al 198825 | Crossover | Cycle ergometry | PEP | 12 | NS | NS | Stable | Respiratory function tests, sputum weight | |||
Lannefors et al 199226 | Crossover | Cycle ergometry | PEP PD with TEE | 9 | 12–36 | 20–78, 51 (NS)‡ | Stable | Mucociliary clearance | |||
Reix et al 2012 (Reix et al 2009)27 | Crossover | Mixed | mACBT | 32 | 12 (3)‡ | 93 (14)§ | 94 (14)§ | Stable | Respiratory function tests, sputum weight, participant satisfaction, adverse events |
*Range unless otherwise specified.
†Mean (SEM).
‡Mean (SD).
§Mean (95% CI).
ACBT with PD, active cycle of breathing technique with postural drainage; ACT, airway clearance technique; CPET, cardiopulmonary exercise testing; mACBT, modified active cycle of breathing technique; NS, not specified; PD with P&V, postural drainage, percussion and vibration; PD with TEE, postural drainage and thoracic expansion exercises; PEP, positive expiratory pressure; ppFEV1, percent predicted forced expiratory volume in one second.